Drug Database
Back to search

Belgium· BE-AMP-SAM403611-00

Tisseel S/D

A lokale hämostatika, kombinationen product containing human thrombin, registered in Belgium by Baxter. The same ATC class is registered in 11 of our 19 countries.

ATC B02BC30

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTisseel S/DATCB02BC30REGISTER NO.BE-AMP-SAM403611-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about human thrombinAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lokale hämostatika, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC B02BC30 (lokale hämostatika, kombinationen), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search lokale hämostatika, kombinationen products by name

Lokale hämostatika, kombinationen · ATC B02BC30

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Human Thrombin
Manufacturer
Baxter
Country
Belgium (BE)
ATC code
B02BC30
ATC class
Lokale Hämostatika, Kombinationen
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    7705239
  • be_apb
    3078235

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lokale hämostatika, kombinationen in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lokale hämostatika, kombinationen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6518b5b7-7559-4f78-ac86-9fe26db2c11e
GET /v1/drugs/6518b5b7-7559-4f78-ac86-9fe26db2c11e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for sealant",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Tisseel S/D",
  "name_fr": "Tisseel S/D",
  "name_nl": "Tisseel S/D",
  "amp_code": "SAM403611-00",
  "strengths": [
    "500.0000",
    "3.5000",
    "72.0000",
    "0.6000",
    "0.6000"
  ],
  "pack_count": 1,
  "substances": [
    "Human Thrombin",
    "Calcium Chloride Dihydrate",
    "Calcium Chloride",
    "Sodium Chloride",
    "Aprotinin",
    "Human Fibrinogen",
    "Factor XIII",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Combinations",
  "authorisation_numbers": [
    "BE403611"
  ]
}
API referenceMCP serverPlans

See everything about lokale hämostatika, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console